Transition Therapeutics (TTHI) Doubles on Purchase by OPKO

Transition Therapeutics Inc. TTHI shares hurtled 110.9% higher to $1.48, on announcing the signing of a definitive agreement under which OPKO Health will acquire Transition Therapeutics, a clinical stage biotechnology company. Share volume was 1.4 million, triumphing over an all-day average of 52,000
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!